![Yanping Ye](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yanping Ye
Hoofd Techniek/Wetenschap/O&O bij Continent Pharmaceutical Inc.
Profiel
Yanping Ye is currently the Director of Research at Continent Pharmaceutical Inc. Prior to this, Dr. Ye worked as the Director of Research & Development at Shanghai Genomics, Inc. from 2016 to 2018.
Dr. Ye earned a doctorate degree from Portland State University in 2012.
Actieve functies van Yanping Ye
Bedrijven | Functie | Begin |
---|---|---|
Continent Pharmaceutical Inc.
![]() Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Hoofd Techniek/Wetenschap/O&O | 01-08-2018 |
Eerdere bekende functies van Yanping Ye
Bedrijven | Functie | Einde |
---|---|---|
Shanghai Genomics, Inc.
![]() Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Hoofd Techniek/Wetenschap/O&O | 01-07-2018 |
Opleiding van Yanping Ye
Portland State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Continent Pharmaceutical Inc.
![]() Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
Shanghai Genomics, Inc.
![]() Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Health Technology |